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Abstract
Elastin-like polypeptides (ELP) and hydrophobins (HFBI) are fusion tags which
enhance the accumulation levels of recombinant proteins in plants and aid in the nonchromatographic purification of these proteins. An intein is inserted between the target
protein and fusion tag to replace the protease cleavage site. In this study, transient
expression of intein-GFP fused to ELP or HFBI in Nicotiana benthamiana yielded the full
size fusion protein. The ELP-fused proteins were successfully purified using inverse
transition cycling (ITC) with 1.0 M NH4(SO4)2 at room temperature. However, the
purification using membrane ITC was unsuccessful due to clogged membrane pores.
Purification of HFBI-fused proteins through aqueous two-phase system (ATPS) using
Triton X-114 was also unsuccessful. The proteins did not separate into the correct phase
for recovery. In crude extract, cleavage of the intein at the C-terminus could be induced
with a pH change, while DTT was not sufficient for cleavage at the N-terminus.

Keywords: elastin-like polypeptides, hydrophobin I, inverse transition cycling, aqueous
two-phase system, intein splicing, recombinant protein production
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CHAPTER 1: INTRODUCTION

1.1 Plants as a Platform for Recombinant Protein Production
With the expanding global market for recombinant proteins in pharmaceutical and
therapeutic applications, the need for cost-effective and efficient ways for the production
of these proteins becomes more prominent. Sales of $36 billion in 2002 grew to $163
billion in 2012 and these numbers are expected to keep rising. In this same time span, the
level of biotechnology product sales as a percentage of total drug sales rose from 8 to 19%
(Evens and Kaitin, 2014). Most commercial human therapeutic proteins are produced in
mammalian and bacterial expression systems (Boehm, 2007). Bacterial systems are often
chosen for their simple and low-cost maintenance, but they lack several post-translational
modifications that are strictly eukaryotic, such as glycosylation and disulfide bond
formation (Gomord and Faye, 2004). Mammalian cultures can provide these necessary
modifications. However, they require costly media components and can carry human and
animal pathogens (Streatfield, 2007).
Plants have recently received attention for the production of recombinant proteins
due to their numerous advantages. One advantage is that plants do not have the potential
to carry animal and human pathogens. They also require less maintenance and costly media
components and are more scalable than other systems such as mammalian cells
(Dingermann, 2008); scalability is an important characteristic when it comes time to
commercialize products. In contrast to bacterial systems, plants can also perform the
necessary post-translational modifications required for many complex eukaryotic proteins
(Pogue et al., 2010; Xu et al., 2011). Post-translational modifications between plants and
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humans are highly conserved with only few minor differences during glycosylation
(Cabanes-Macheteau et al., 1999). These differences in glycosylation are added as the
protein passes through the Golgi (Gomord and Faye, 2004). To avoid passing through the
Golgi, a C-terminal motif consisting of lysine, aspartic acid, glutamic acid and leucine
(KDEL) is added for endoplasmic reticulum (ER) retrieval and retention (Lord and
Roberts, 1998). As well, it was found that levels of accumulation for recombinant proteins
increased when the proteins were retained in the ER (Menassa et al., 2001).
Although the advantages of plant platforms are many, several limitations still exist.
These include low protein accumulation levels and inefficient and costly purification
methods. Typical levels of recombinant protein yielded in plants range from 0.1% to 1.0%
of total soluble protein (TSP; Hood et al., 2002). The most common purification procedures
require the use of affinity chromatography. The regeneration of the resins for
chromatography in addition to the use of proteases for the removal of a fusion tag increases
the cost of purification (Chapman, 2005). In a material cost comparison study by Banki
and Wood (2005), the cost to purify 1 kg of protein product with a fusion tag, including
the removal of it, was upwards of $9.6 million, where approximately $8.4 million was for
the cost of the protease alone. Therefore, the search for more effective and economical
purification methods is ongoing.

1.2 Transient Expression of Proteins in Nicotiana benthamiana
Tobacco has become a favourite plant for recombinant protein production because
of several distinct benefits including a large amount of leaf biomass, simple transformation
and established transient expression methods currently used commercially. The relative of
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tobacco, Nicotiana benthamiana, is the main model used for transient expression of
recombinant proteins through infiltration of Agrobacterium carrying the gene of interest
into the leaves of the plant. This method is more commonly called “agroinfiltration”.
Infection begins when Agrobacterium tumefaciens containing a binary expression vector
is infiltrated into the leaves of the host plant by vacuum infiltration or syringe injection
(Kapila et al., 1997). Single-stranded T-DNA then moves from Agrobacterium into the
plant cells, where it is trafficked into the nucleus via chaperones (Zambryski, 1988).
Although much of the T-DNA does not integrate into the host chromosomes in the short
time frame of transient transformation, the free T-DNA copies are still transcriptionally
active (Voinnet et al., 2003). This allows for tissue samples to be harvested 2-5 days post
infiltration, whereas with stable transformation, regeneration of transgenic plant lines can
take up to 3-6 months depending on the species (Kapila et al., 1997; Sparkes et al., 2006).
Also, as expression is not dependent on transcriptional activity of a chromosome insertion
site, insertion position effects are not observed. As well, multiple genes can be expressed
simultaneously within the same host (Kapila et al., 1997). This can be used to achieve
production of complex proteins such as antibodies. The speed of transient expression also
allows screening of multiple genes in a short time span.

1.3 Fusion Tags for Increased Accumulation and Simplified Purification
Advances for purification of proteins without the use of chromatographic methods
include the addition of fusion tags to a protein of interest. Elastin-like polypeptides (ELP)
and hydrophobin I (HFBI) are both fusion tags which have been shown to increase
accumulation of recombinant proteins (Patel et al., 2007; Conley et al., 2009; Joensuu et
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al., 2010), while aiding in non-chromotographic purification. ELPs are a synthetic
polypeptide composed of an elastin-derived repeating pentapeptide motif: VPGXG, where
X is any amino acid except proline (Urry et al., 1985; Urry, 1992). They have the property
of being able to undergo a reversible inverse phase transition (Urry 1992; 1997) and this
property can be transferred to a fused partner (Meyer and Chilkoti, 1999). With this
knowledge, purification of ELP-fused proteins could be carried out using a simple method
called inverse transition cycling (ITC; Fig. 1). This method works by raising the
temperature above the ELP’s transition temperature (Tt) and/or increasing the salt
concentration changes the ELP’s conformation and causing aggregation of the ELP fusion
protein. The ELP aggregates can then be isolated and resolublized in an aqueous solution
at a temperature lower than the Tt. According to Urry et al. (1985), when phase transition
is induced, aggregation does not denature the fusion protein as only the ELP portion
aggregates. Also, these aggregates have a radius larger than one micron (Meyer et al., 2001;
Meyer and Chilkoti, 2002a), allowing these fusion proteins to be captured by membrane
microfiltration ITC (mITC; Ge et al., 2006). All these properties give ELP-fused proteins
a special advantage in biotechnological fields where low cost and high efficiency large
scale purification is desirable.
Transition temperature is mainly dependent on two factors: the concentration of the
ELP fusion protein and the solution composition, especially its ionic strength. As the
concentration of ELP increases, the Tt decreases logarithmically (Meyer and Chilkoti,
2002b). Increasing the concentration of NaCl, the most commonly used salt, also decreases
the transition temperature. As a rule of thumb, the Tt is lowered by ~15°C
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Figure 1. Schematic of inverse transition cycling and membrane inverse transition
cycling. In centrifugation ITC (A) and membrane ITC (B), heat and/or salt is added to
induce aggregation of the ELPs. The aggregates are then isolated either by centrifugation
(A) or membrane filtration (B) and resolubilized prior to intein cleavage. To complete the
purification process, after cleavage, aggregation of the ELP is induced again to separate
out the ELPs from the protein of interest.
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for every 1 M NaCl increase. However, the efficiency of the aggregation and precipitation
of the ELP fusion proteins also depends on the effects of the ions in the solution. This
effectiveness follows the Hofmeister series, which ranks ions based on their kosmotropic
nature and their effect on protein solubility (Cacace et al., 1997). Kosmotropic ions, or ions
that contribute to the stability of water-water interactions, exceed chaotropic ions, which
disrupt the hydrogen bonding network between water molecules, in their ability to
precipitate proteins. Chloride and sodium are both ranked in the middle of the Hofmeister
series. Fong et al. (2009) conducted a comparative study of different salts under the
assumption that a more kosmotropic salt such as ammonium sulfate would be a better
precipitant of proteins than sodium chloride. Their results showed that ammonium sulfate
concentrations could be used at 27% of sodium chloride to obtain the same effect on ELP
precipitation. As well, this reduces the Tt from 37°C to about 23°C, eliminating the need
for additional energy to heat the solution.
The levels of accumulation and efficiency of purification of ELP-fused proteins
also depends on the size of ELP, as determined by the number of pentapeptide repeats.
More efficient purification can be achieved with longer ELP segments, but results in lower
levels of protein accumulation (Conley et al., 2009). Conversely, shorter ELP segments
generally result in higher accumulation levels but less efficient purification. Currently, the
efficiency of purification of a protein of interest from plant extracts using shorter ELPs is
low and affinity chromatography methods are still required to obtain high purity (Joensuu
et al., 2010). With ELP110 fused to either β-lactamase or to green fluorescent protein (GFP)
expressed in E. coli resulted in recoveries of 80% and 50%, respectively, demonstrating
that the fusion partner may also influence purification efficiency (Fong et al., 2009).
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Hydrophobins are globular proteins produced by filamentous fungi that are able to
form layers at water-air surfaces (Whiteford and Spanu, 2002). In this study, I used
hydrophobin I (HFBI), which originates from Trichoderma reesei and is about 7.5 kDa in
size. Although there are different classes of hydrophobins, one common characteristic is
the eight Cys residues that form four intramolecular disulfide bridges, which increase the
stability of the protein structure (Hakanpaa et al., 2004). Their unique amphipathic property
allows hydrophobins to be purified using a liquid-liquid extraction in an aqueous two-phase
system (ATPS) and this property can be transferred to their fused partners (Linder et al.,
2004; Lahtinen et al., 2008). Purification using ATPS allows the phase separation of
hydrophobic and hydrophilic proteins through the addition of a surfactant (Fig. 2). When
HFBI-fused proteins form micelles, the fusion protein is pulled into the surfactant
(hydrophobic) phase. Isobutanol is added to remove the surfactant and the purified fusion
protein settles in the aqueous phase. Recovery of GFP fused to HFBI with ATPS resulted
in about 91% (Joensuu et al., 2010).
Despite the improvements to accumulation levels and purification methods, the
addition of fusion tags has its disadvantages. If a fusion tag is used, it must be cleaved prior
to any usage where a purified untagged product is required. The Tobacco Etch Virus (TEV)
protease site consisting of seven amino acids ENLYFQG is commonly inserted between a
protein of interest and its fused tag to allow for separation following purification. Cleavage
with the TEV protease occurs between the Q and G, leaving either six (ENLYFQ) or one
amino acids (G) on the resulting fragments. The potential issue with extra amino acids is
demonstrated in recombinant antibody/antigen production, where a single amino acid can
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(A)

(B)

Figure 2. Conceptual schematic of aqueous two-phase system purification of a GFPintein-HFBI fusion protein. (A) In ATPS, the first phase separation is induced by the
addition of a surfactant. Isobutanol is added to the micelle-rich (surfactant) phase to remove
the surfactant. In the second phase separation, the purified fusion protein is separated from
the isobutanol-surfactant mixture. (B) The purified fusion protein is then treated with a
reagent to induce intein cleavage. Following cleavage, GFP is isolated from intein-HFBI
by the addition of surfactant. Modified from Yan (2011).

8

alter the entire interaction between antigen and antibody (Colman, 1994). The cost of using
a protease site for the removal of a fusion tag is very high and large scale purification using
this method is, therefore, infeasible. As an alternative, the TEV protease (or any other
protease) site can be replaced by an intein, and the N- and/or C-terminal integrity can be
maintained when the intein is spliced. This means that the termini regain a normal peptide
group (i.e. an amine or carboxyl group), leaving no residual amino acids.

1.4 Inteins
In a comparative study in 1987 between Daucus carota (carrot) and Neurospora
crassa vacuolar ATPases and a putative calcium ion pumping ATPase, the first intein was
discovered (Shih et al., 1988). This putative ATPase was isolated when it was found that a
mutation in its gene made yeast resistant to trifluoperazine. When this gene was compared
to the vacuolar ATPase subunits, it was found that the beginnings and the ends of the
sequences were similar, but the middle portion contained an endonuclease-like insertion.
Hirata et al. (1990) isolated cDNA for a vacuolar ATPase from Saccharomyces cerevisiae
and found a sequence similar to the trifluoperazine resistant gene inserted within the gene.
Interestingly, the molecular weight of the yeast V-ATPase was found to be the same as a
subunit which contained no insertion. Kane et al. (1990) showed that this insertion was
included in the mRNA and translated, but spliced post-translationally.
Inteins are found in all three domains of life: bacteria, eukaryotes and archaea. Few
inteins have been identified in eukaryotes and the majority of inteins discovered have been
found in bacteria and archaea. They get their name from “internal” or “interrupting”
proteins and they function analogously to introns in RNA. However, unlike introns, inteins
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are translated with their host protein prior to splicing. There are many studies which suggest
that, since there is similarity between the endonuclease motifs of inteins and mobile introns,
inteins may be involved in intein homing just as mobile introns are involved in intron
homing (Belfort et al., 1995; Colston and Davis, 1994; Cooper and Stevens, 1995).
The vast majority of reported inteins consist of two domains: an endonuclease
domain and a self-splicing domain where the C- and N-termini have the necessary
characteristics to allow for splicing (Liu, 2000). Smaller inteins called mini-inteins consist
of only the self-splicing domain. Found in almost 80% of known inteins, the most common
endonuclease motif is a dodecapeptide LAGLIDADG/HNH (Perler, 2000). Although the
deletion of the endonuclease does not affect protein splicing in the large inteins (Chong
and Xu, 1997), it is proposed that the endonuclease plays an important role in the spreading
of inteins (Liu, 2000). This supports the idea of inteins being mobile genetic elements.
Although inteins are found in diverse proteins such as metabolic enzymes,
proteases, and DNA and RNA polymerases, most are found in enzymes related to DNA
replication and repair (Liu, 2000). Chute (1998) gives two reasons why inteins appear to
be biased towards these types of host proteins. The first stems from the theory of intein
homing. Intein homing means that in a cell which has an intein-containing allele and an
intein-less allele, the endonuclease will identify and cleave the intein-less allele at the
insertion/homing site. The double-stranded DNA breaks and triggers the repair system.
This allows the intein to be inserted into the intein-less allele using the intein-containing
allele as template. To prevent cleavage of the new intein-containing DNA, the insertion is
made at a homing site which disrupts the original endonuclease recognition site (Liu,
2000). Chute (1998) suggests that inteins found in host proteins related to DNA replication
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and repair are more adapted for intein homing. The host protein and intein are produced at
the same time, ensuring that the endonuclease is produced during periods of active DNA
replication and repair. This means that when a double-stranded DNA break occurs at the
homing site and the intein is introduced to the intein-less allele, replication and repair
proteins are able to fix the break promptly and complete the homing process.
The second explanation why inteins are biased towards replication and repair
proteins is the potential hazard the endonuclease has on the host cell’s chromosome. If the
intein and the host protein are not yet an established pair, then a new intein may
accidentally recognize and break the chromosome at regions other than the intended
homing site. Chute (1998) suggests that the cell’s response to reduce this risk is to restrict
the production of intein endonucleases only to times of active DNA replication and repair.
This can minimize and quickly rectify the damage done to the chromosome without
affecting chromosome integrity and cell viability.

1.5 Intein Cleavage
After translation, the intein splices and leaves the two parts of the host protein
(exteins or “external proteins”) to rejoin via a peptide bond and resume normal function
(Cooper and Stevens, 1995; Dujon, 1989; Perler et al., 1994). A quick overview of intein
splicing (Chong et al., 1997) is as follows (Fig. 3):
Step 1. At the N-terminus, a spontaneous N-O or N-S acyl shift forms an ester or
thioester intermediate. This will lead the N-extein to bind to the oxygen of the serine
or sulfur of the cysteine residue at the N-terminus of the intein.
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Step 2. The nucleophilic residue at the C-terminus will attack the (thio)ester bond
during transesterification, cleaving it. This leaves a branched protein intermediate.
Step 3. Immediately following transesterification, the asparagine at the C-terminus
undergoes cyclization, cleaving the intein through a succinimide intermediate.
Step 4. A spontaneous N-S acyl shift reforms the peptide bond between the exteins.

Because of their self-catalyzed splicing nature, inteins are used in biotechnological
applications as a substitute to proteases but it can still result in unwanted in vivo splicing
prior to purification. Hence, a regulated intein was designed for controlled splicing. The
Mycobacterium tuberculosis RecA intein was modified by inserting a human estrogen
receptor ligand binding domain (LBD) to disrupt intein folding and prevent splicing
(Buskirk et al., 2004). This LBD has a high affinity for the synthetic molecule
4-hydroxytamoxifen (4-HT). When 4-HT is bound to the LBD, intein structure is restored
and splicing can occur. This engineered intein was termed a “small-molecule dependent”
intein. However, Buskirk et al. (2004) found that the insertion of control splicing at either
the C-terminus or the N-terminus. By changing asparagine (Asn) to alanine (Ala) at the
C-terminus of the intein, asparagine cyclization is prevented, thereby inhibiting splicing at
that terminus (Fig. 4C). Substituting Ala for cysteine (Cys) at the N-terminus disrupts the
N-S acyl shift required for splicing the intein from the N-extein (Evans et al., 2005;
Fig. 4B). A third modification was designed to enhance the rate of the LBD did not result
in ligand-dependent splicing but only reduced in vivo splicing activity.
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Figure 3. Diagram of steps involved in intein cleavage. Cleavage starts with a
spontaneous N-S acyl shift, allowing the intein to undergo a transesterification to displace
the N-extein onto the C-extein. Following that, cyclization of asparagine at the C-terminus
cleaves the joined exteins, forming succinimide in the process. Finally, an O-N acyl shift
forms the peptide bond and the intein is successfully cleaved from the two exteins.
Modified from Mathys et al. (1999).

13

To adapt this intein to recombinant fusion protein production and purification in
plants, Hendy (2009) modified the intein further. Terminal amino acids were modified to
cleavage at the C-terminus. This was achieved by replacing the aspartic acid (Asp) at
position 394 with glycine (Gly) of the C-intein to prevent hydrogen bonding at the
C-terminus, allowing for premature succinimide formation. In addition to these changes,
the two exteins (Fig. 4A) were replaced by an intact protein of interest at one terminus and
a fusion tag at the other. Hendy (2009) experimented with the three different intein
constructs expressed in tobacco BY-2 (bright yellow) cell suspensions: the N-intein for
N-terminal cleavage, the C-intein for C-terminal cleavage, and the S-intein for enhanced
C-terminal cleavage, each tagged with an ELP 30, 60 or 90 pentapeptide repeats in length.
Research from Chong et al. (1997) showed that by adding a reducing agent such as
dithiothreitol (DTT), the N-S equilibrium can be shifted by attacking the thioester and
inducing the N-terminal cleavage. Wood et al. (1999) discovered that the His before the
Asn at the C-terminus allowed for pH-based cleavage at that terminus. Histidine also acts
as a proton donor to promote the formation of succinimide, thereby resulting in C-terminal
cleavage. Hendy (2009) noted that 4-HT was not required in the splicing of the inteins, but
a change in pH to 5.5 was sufficient for C-terminal cleavage. No cleavage at the N-terminus
was observed. In a study by Linder et al. (2001), different pH of extraction buffers were
tested for determining efficiency of purification by ATPS. They found that pH did not
significantly hinder the partitioning of HFBI during ATPS. Therefore, a change in pH when
cleaving the intein should not affect the overall purification process of HFBI. There is no
literature for the effects of DTT on ATPS as of yet. However, since HFBI is
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(A)

(B)

(C)

Figure 4. Modifications of an intein to promote ease in separation of target protein
and fusion tag. (A) The original intein with the native Cys and Asn terminal amino acids.
The intein is flanked by the N-extein and C-extein. (B) N-cleaving intein: the Asn at the
N-terminus is replaced by Ala and the two exteins are replaced by the target protein and
the fusion tag. Addition of 50 mM DTT aids in cleavage of the target protein at the
N-terminus from the intein-fusion tag. (C) C-cleaving intein: the Cys at the C-terminus is
replaced by Ala and the two exteins are replaced by the fusion tag and target protein. A
change in the pH to 5.5 results in the cleavage of the target protein from the intein-fusion
tag complex.
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held together by four disulfide bonds, it is expected that DTT would reduce these bonds
and unfold the HFBI protein.
Using all of this background knowledge, a protein fused to an intein and either ELP
or HFBI is predicted to result in increased accumulation levels and easier purification. The
simple steps of both ITC (Fig. 1) and ATPS (Fig. 2) should allow for quick purification of
the fusion protein, followed by cleavage of the intein-tag fusion and one additional step to
segregate the protein of interest from the tag. This project intends to test the functionality
and efficiency of intein-HFBI and intein-ELP fusions in the purification of the target
protein, GFP, when transiently expressed in Nicotiana benthamiana. This could create a
more rapid and cost-efficient method for purifying recombinant proteins from crude plant
extracts.

1.6 Hypotheses
Based on previous literature about the expression of GFP-ELP and GFP-HFBI in
plants, GFP-HFBI with an accumulation level of up to 51% TSP (Joensuu et al., 2010)
outperforms the 21% TSP accumulation level of GFP-ELP10 (Conley et al., 2009). As the
intein incorporated between the GFP and the fusion tag (ELP or HFBI) is very large, it can
be predicted to accumulate at lower levels than a fusion protein without the intein. As well,
based on purification recovery reported by these two studies, the 91% recovery of GFPHFBI through ATPS (Joensuu et al., 2010) greatly surpasses the 60% recovery of GFPELP20 using ITC (Conley et al., 2009). Therefore, I hypothesize that the GFP-intein
constructs fused to HFBI will accumulate at higher levels and result in higher recovery of
the fusion protein than when fused to ELP.
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Preliminary results for intein cleavage conditions for this modified small-molecule
dependent intein were previously tested in BY-2 tobacco cells (Hendy, 2009). It was
discovered that cleavage of GFP could be induced by a change in pH to 5.5 for the
C-terminus cleaving intein. However, cleavage at the N-terminus could not be induced. I
hypothesize that both cleavage conditions will work for their respective inteins but the
efficiency of the N-terminus cleaving intein with DTT will not be as high as for the
C-terminus cleaving intein with a pH change.

1.7 Objectives and Approaches
1. Determine accumulation levels of intein-ELP constructs (Hendy, 2009) using
transient expression in N. benthamiana through agroinfiltration.
2. Design GFP-intein-HFBI constructs and determine the accumulation levels in
N. benthamiana through agroinfiltration.
3. Determine optimal conditions for purification of ELP-fused and HFBI-fused
proteins using ITC and ATPS, respectively.
4. Determine efficiency of intein cleavage in crude extract of ELP and HFBI fusion
proteins for removal of intein-ELP or intein-HFBI.
5. If successful, fusion proteins will be purified, cleaved and GFP will be recovered
via another partial round of the respective purification.
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CHAPTER 2: MATERIALS AND METHODS

2.1 Common Media, Solutions and Reagents
2.1.1 Media and Media Components
Antibiotics
Ampicillin (100 mg/ml) and kanamycin (100 mg/ml) stocks were prepared by dissolving
the antibiotic in milliQ water and filter sterilizing. Rifampicin stock (10 mg/ml) was made
by dissolving antibiotic in 100% methanol and filter sterilizing. Aliquots were stored
at -20°C.

Gamborg’s Solution
Per 100 ml: 0.32 g Gamborg’s B5 + vitamins (Research Products International Corp.,
G20200), 2 g sucrose, 1 ml MES (1 M), 100 µl acetosyringone (200 mM).

Infiltration Medium
Per 100 ml: 100 ml YEB, 1 ml MES (1 M), 50 µl acetosyringone (200 mM), 50 µl
kanamycin (100 mg/ml), 100 µl rifampicin (10 mg/ml).

200 mM Acetosyringone
Per 100 ml: 0.392 g acetosyringone was dissolved in ethanol. Aliquots were stored
at -20°C.
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1 M Morpholinoethanesulfonic Acid (MES) pH 5.6
Per 100 ml: 19.50 g MES was dissolved in milliQ water. Adjusted pH to 5.6 with
KOH. Aliquots were stored at -20°C.

Luria-Bertani (LB) Broth
Per L: 10 g NaCl, 10 g tryptone and 5 g yeast extract were added to milliQ water. Adjusted
pH to 7.0. For solid media, a pre-mixed LB agar mixture (QIAgen) was used.

Yeast Extract Broth (YEB)
Per L: 5 g beef extract, 1 g yeast extract, 5 g peptone, 5 g sucrose and 2 mM MgSO4 were
added to milliQ water. Adjusted pH to 7.2. For solid media, 14 g of agar was added.

2.1.2 Solutions and Reagents
10X Phosphate Buffer Solution (PBS)
Per L: 80 g NaCl, 2 g KCl, 14.4 g Na2HPO4 and 2.4 g KH2PO4 was dissolved in milliQ
water. The pH was adjusted to 7.4.

1X PBS-Tween (PBS-T)
Per L: 100 ml 10X PBS was diluted in 899 ml milliQ water and 1 ml Tween-20 was added.

50% Glycerol (v/v)
Per 100 ml: 50 ml glycerol was added to 50 ml milliQ water. Solution was filter sterilized
and stored at room temperature.
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Protein Extraction Buffer (PEB)
Per 10 ml: 9.6 ml 1X PBS-T, 0.2 g polyvinylpolypyrrolidone (PVPP), 20 µl EDTA (0.5 M),
100 µl PMSF (100 mM), 10 µl leupeptin (1 mg/ml), 0.2 g sodium ascorbate. PVPP was
allowed to hydrate for 2-24 h before use. Leupeptin and PMSF were added immediately
before use.

0.5 M Ethylenediamine-tetraacetic acid (EDTA) pH 8.0
Per 50 ml: 9.3 g EDTA disodium salt dehydrate was added to 30 ml milliQ water.
NaOH was used to adjust pH to 8.0 and topped to 50 ml with milliQ water. Solution
was stored at room temperature.

1 mg/ml Leupeptin
Per 100 ml: 0.1 g leupeptin was dissolved in milliQ water. Aliquots were stored
at -20°C.

100 mM Phenylmethanesulfonyl Fluoride (PMSF)
Per 100 ml: 1.74 g PMSF was dissolved in 100 ml isopropanol. Aliquots were
stored at -20°C.

50 mM Tris-HCl, 0.1% v/v Triton X-100 Extraction Buffer (TEB)
Per L: 6.07 g Trizma-base was dissolved in MilliQ water. The pH was adjusted to 8.0 and
1 ml Triton X-100 was added. The buffer was supplemented with 100 µl PMSF (100 mM),
10 µl leupeptin (1 mg/ml).
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Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) Solutions
5X Reducing SDS Sample Buffer
Per 10 ml: 3 ml 1 M Tris-HCl pH 8.0, 0.5 g SDS, 5 ml 50% glycerol, 1 ml DTT
(1M), 5 mg Phenol Red were added to milliQ water. Aliquots were stored at -20°C.

10% Ammonium Persulfate (APS)
Per 1 ml: 0.1g ammonium persulfate was dissolved in milliQ water.

10% Sodium Dodecyl Sulfate (SDS)
Per 100 ml: 10 g SDS was added to milliQ water and stored at room temperature.

0.5 M Tris-HCl pH 6.8 (Stacking Gel Buffer)
Per 100 ml: 6 g Tris base was dissolved in milliQ water. The pH was adjusted to
6.8 with HCl and stored at room temperature.

1.5 M Tris-HCl pH 8.8 (Separating Gel Buffer)
Per 100 ml: 18.15 g Tris base was dissolved in milliQ water. The pH was adjusted
to 8.8 with HCl and stored at room temperature.

5X Tris-Glycine SDS (TGS) Running Buffer
Per L: 15 g Tris base, 72 g glycine and 5 g SDS were added to milliQ water and
stored at room temperature.
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1X TGS Running Buffer
Per L: dilute 100 ml 5X TGS Running Buffer in 900 ml milliQ water and stored at
room temperature.

Immunoblot Solutions
Western Transfer Buffer (10% Methanol)
Per L: 3.03 g Tris base, 24.41 g glycine were added to milliQ water, topped to
volume of 800 ml. Then 200 ml methanol was added.

5% Blocking Solution
Per 50 ml: 2.5 g Carnation skim milk power was dissolved in 1X TBS-T and stored
at 4°C.

10X Tris-Buffered Saline (TBS)
Per L: 24.2 g Tris base and 175.3 g NaCl were added to milliQ water. The pH was
adjusted to 7.5 and stored at room temperature.

1X TBS-Tween (TBS-T)
Per L: 100 ml 10X TBS and 1 ml Tween-20 were added to 899 ml milliQ water and
stored at room temperature.
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Intein Cleavage Solutions
4-Hydroxytamoxifen (4-HT)
Per 5 mg 4-HT (Sigma-Aldrich, H7904-5MG): dissolve in 250 µl 95% ethanol at
50°C. Stock concentration was diluted to 10 mM with 95% ethanol and stored in
the dark at -20°C. The working concentration is 10 µM.

1 M Dithiothreitol (DTT)
Per 100 ml: 15.45 g DTT was dissolved in milliQ water. Aliquots were stored
at -20°C.

2.2 Strains and Plasmids
2.2.1 Strains and Growth Conditions
Escherichia coli strain XL1-blue (Agilent Technologies, Cat. No. 200301) was
used for the amplification of plasmid DNA. The bacteria were grown at 37°C on LB plates
or in liquid LB broth supplemented with antibiotics. Agrobacterium tumefaciens strain
EHA105 (Hood et al., 1993) was chosen for the infiltration of the gene of interest into
N. benthamiana. Agrobacterium tumefaciens was grown at 28°C on YEB plates or in YEB
medium supplemented with appropriate antibiotics.

2.2.2 Plasmids
The cloning vector used in this study was pBluescript II KS+ (Strategene, Cat. No.
12207). The order of restriction enzyme cut sites in the multiple cloning site (MCS) made
it an ideal candidate for the purpose of cloning. It is also a high copy plasmid, thus optimal
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in amplifying plasmid DNA. The construct containing the gene of interest was then cloned
into pCaMterX (Harris and Gleddie, 2001), the plant binary vector used for plant
transformation. This vector consists of a double enhanced constitutive cauliflower mosaic
virus 35S promoter, a multiple cloning site and a nopaline synthase (NOS) terminator
(Odell et al., 1985).

2.3 Design of Constructs and Cloning Procedures
2.3.1 Design of Intein-HFBI Constructs
Based on the design of the intein-ELP constructs, the elastin-like polypeptide was
replaced by a hydrophobin I sequence. Differing from the intein-ELP constructs, (GGGS)3
and/or Aspergillus niger glucoamylase G1 linkers (SGSVTSTSKTTATASKTSTST) were
placed between the HFBI and the intein to allow for more space for the HFBI to fold
properly.
These constructs were synthesized commercially by Eurofins Genomics in the
pUC57 vector. The resuspended plasmid DNA was used to transform E. coli cultures which
were grown overnight at 37°C in an orbital shaker at 250 rpm.

2.3.2 Cloning of HFBI Constructs
Plasmid DNA from the overnight E. coli cultures were isolated using the QIAprep
Spin Miniprep Kit (QIAgen, Cat. No. 27106). After plasmid DNA was digested with the
appropriate restriction enzymes (RE; Invitrogen and New England Biolabs) to isolate the
construct, it was inserted into one of two vectors: pBluescript II KS+ for plasmid DNA
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amplification; or pCaMterX for agroinfiltration. Ligation was mediated by the T4 DNA
ligase (Invitrogen, Cat. No. 15224-017) following the manufacturer’s protocol.

2.4 Escherichia coli and Agrobacterium tumefaciens Transformation
Constructs were transformed into electrocompetent E. coli XL1-blue or
A. tumefaciens EHA105 cells using electroporation. A 0.2 cm Gene Pulser Cuvette (Bio
Rad) was placed on ice prior to transformation. Once cooled, 1 µl of plasmid was added to
50 µl of electrocompetent cells and transferred to the cuvette. Following the manufacturer’s
instructions, an electrical pulse was administered to the cuvette containing the cell
suspension. One millilitre of medium was immediately added to the cuvette and transferred
to a sterile 1.5 ml Eppendorf tube. The tube was incubated at 37°C for E. coli or at 28°C
for A. tumefaciens in a horizontal shaker at 250 rpm for one hour. A portion of the cells
(50 and 100 µl) were then plated onto LB or YEB plates with the appropriate antibiotics.
Positive transformants were identified and grown in 5 ml of LB media containing
the appropriate antibiotic. Stocks were created using 750 µl of the overnight culture and
250 µl of 50% glycerol, mixed in a cryogenic vial and flash frozen in liquid nitrogen before
being stored at -80°C.

2.5 Transient Expression in N. benthamiana Leaves
Plates were streaked using the A. tumefaciens stock cultures and grown at 28°C for
two nights. Colonies were picked and grown in liquid medium (YEB supplemented with
the appropriate antibiotics) overnight at 28°C. This culture was used to inoculate the
infiltration liquid culture. These cultures were grown overnight in infiltration medium at
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28°C in an incubator shaker at 250 rpm. Cells were pelleted at room temperature at
3000 rpm for half an hour. The supernatant was discarded and the pellet was resuspended
in Gamborg’s solution to an ODA600 = 0.6. This cell suspension was incubated for an hour
at room temperature.
After incubation, the Agrobacterium suspension containing the gene of interest was
mixed at equal volumes with an Agrobacterium suspension of p19, a suppressor of posttranscriptional gene silencing (PTGS). The p19 is from the Cymbidium ringspot virus
(Silhavy et al., 2002). Because transcription levels of foreign DNA are reduced due to
PTGS, it is necessary to co-infiltrate the gene of interest with a suppressor of PTGS
(Voinnet et al., 1999). This allows for increased expression of recombinant proteins
through agroinfiltration (Voinnet et al., 2003). This mixture was infiltrated into the leaves
with a needleless 1mL syringe (Santi et al., 2008). Using a needle, a scratch was made on
the underside of the leaf and the mixture was infiltrated from that point. Samples (whole
leaves or leaf disks using a size 4 cork borer, approx. 8 mm in diameter) were collected
four days post infiltration (dpi). Leaf disks were placed into 2 ml Eppendorf tubes with
three zircon beads (BioSpec Products Inc., Cat. No. 11079125z) while whole leaf tissue
was placed into a plastic bag. Samples were flash frozen using liquid nitrogen and stored
at -80°C.

2.6 Protein Extraction
Method A: Leaf disks
Samples were homogenized using the Tissue Lyser (QIAGEN) for 60 s, turned
over and homogenized for another 60 s. The homogenized tissues were centrifuged at
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4000 rpm for a minute. Then 200 µl of protein extraction buffer was added per three leaf
disks. This mixture was vortexed for 15 s and centrifuged down at 14,000 x g for five min
at 4°C. The supernatant was transferred to a new 1.5 ml tube and centrifuged again. The
supernatant was transferred to a new tube for further analysis. The TSP in the samples was
quantified using the Bradford assay (Bradford, 1976).

Method B: Whole leaf tissue
For experiments requiring larger amounts of crude extract, this method was used.
Samples were homogenized manually using a pre-cooled mortar and pestle. The samples
were removed from the freezer and quickly crushed. A pinch of sand was added to ease the
grinding. Protein extraction buffer was added in a 1 g tissue to 3 ml buffer ratio. Samples
were centrifuged at 15,500 x g for 15 min at 4°C. The supernatant was transferred to a new
tube and centrifuged, then transferred to a new tube for further analysis. Total soluble
protein was determined by the Bradford assay.

2.7 Protein Quantification
2.7.1 SDS-PAGE and Staining
TSPs were separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis
(SDS-PAGE; Laemmli, 1970) on a 4% stacking and 10% separating SDS-PAGE gel. Gels
were run at 120 V until the gel front reached the bottom of the gel.
Gels were stained for an hour in GelCode Blue (Thermo Scientific) before
destaining overnight in milliQ water. Known concentrations of bovine serum albumin
(BSA) were run alongside the samples for quantification.
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2.7.2 Immunoblotting
Gels were transferred to a PVDF membrane (Bio Rad, Cat. No. 162-0184) using a
Trans-blot Semi-dry Transfer Cell (Bio Rad) or a Trans-Blot Turbo Transfer System (Bio
Rad). Membranes were blocked overnight at 4°C in a 5% blocking solution. Afterwards,
the membranes were incubated in 0.5% blocking solution with the primary antibody,
monoclonal mouse anti-GFP (Living Colours, Cat. No. 632381), at a 1:5000 dilution at
room temperature for an hour. Membranes were washed prior to incubation with the
secondary horseradish peroxidase (HRP)-conjugated goat anti-mouse antibody (Bio Rad,
Cat. No. 170-6515) in a 1:5000 dilution for another hour. The membrane was detected with
ECL chemiluminescent detection solutions (GE Healthcare, Cat. No. RPN 2106) according
to the manufacturer’s protocol and visualized on developing film or by a MicroChemi
chemiluminescent system (Neutec Group Inc., Farmingdale, USA).

2.7.3 Fluorometry
Using a 96-well black Costar system (Corning, Cat. No. 07-200-627), samples
expressing GFP were quantified using fluorometry instead of the traditional
immunoblotting. Standards were made from a sample with a known concentration of GFPHFBI in 1X PBS. A dilution series for each sample was prepared, usually a 1/10 and 1/50
dilution. For each sample, three technical replicates were analyzed. The plate(s) were
placed inside a Synergy 2 Microplate Reader (BioTek Instruments Inc., Winooski, USA).
Excitation and emission were set at 485 nm and 516 nm, respectively. The results from
fluorometry were recorded as the % GFP/TSP.
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2.8 Purification
2.8.1 Aqueous Two-Phase System
Following protein extraction (section 2.6) with PEB, samples were incubated at
23°C for 10 min. The warmed crude extract was added to a clear tube with 4% w/v ratio of
surfactant (Triton X-114 or Agrimul NRE 1205). The samples were incubated for an hour
at room temperature or until distinct phases were seen, up to two hours. Samples were then
centrifuged at 3000 rpm for 15 min. The surfactant phase was extracted and transferred to
another tube. Isobutanol was added to the surfactant phase at a 10:1 ratio to the amount of
surfactant added, left to settle, and centrifuged at 3000 rpm for 15 min before the purified
protein layer was recovered.

2.8.2 Inverse Transition Cycling
Following protein extraction (section 2.6) with TEB, the extract was added to a tube
containing pre-weighed (NH4)2SO4 in concentrations varying from 0.2 M to 1.0 M. The
salt was dissolved prior to incubation at one of three temperatures for 30 min: 23°C, 30°C
and 37°C. After incubation, the sample was centrifuged at 20,000 x g for 40 min at the
appropriate temperature (i.e. same as incubation). After removal of the supernatant from
the “hot spin”, the pellet was resuspended in 1/8 of the sample volume with cold TEB. On
ice, the pellet was resuspended using the Sonic Dismembrator Model 100 (Fisher
Scientific, Ontario, Canada) at a setting of 5 for 15 s twice. This was placed on a horizontal
shaker at 4°C for 30 min to allow for resolubilization. The sample was then centrifuged for
10 min at 20,000 x g at 4°C. The purified product from the “cold spin” was collected. The
pellet was resuspended in 1/8 of the sample volume in TEB for analysis.
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2.8.3 Membrane Inverse Transition Cycling
After protein extraction (2.6) with TEB, the extract was pre-filtered using vacuum
filtration with 0.22 µm PVDF Durapore Membrane Filters (Millipore Ltd, Cat. No.
GVWP04700). Ammonium sulfate was added to the extract at the correct concentration
and dissolved completely before continuing onto the next step. The samples were incubated
at room temperature for 30 min before being filtered again. This step leaves the ELP-fused
proteins trapped above the membrane. The membrane was then washed with ammonium
sulfate of the same concentration and temperature. Elution by gravity at 4°C was performed
as an overnight step with half the sample volume of cold TEB to obtain the purified
product.

2.9 Separation and Recovery of GFP
2.9.1 Intein Cleavage
Crude extract samples were treated with different cleaving agents according to the
intein. The C-terminus cleaving intein samples were subjected to three conditions: pH
change to 5.5, addition of 4-HT to a concentration of 10 µM, and a combination of both.
For the N-terminus cleaving intein samples, the three conditions were: addition of DTT to
a concentration of 50 mM, addition of 4-HT to a concentration of 10 µM, and a
combination of both. A negative control of just the crude extract was also analyzed. All
samples were incubated overnight (18-24 hours) in a water bath at room temperature.
Samples were properly mixed prior to taking a portion for SDS-PAGE. After determination
of the most successful treatment, intein cleavage of the purified samples was induced using
that agent.
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2.9.2 Cleavage of ITC-Purified ELP Fusions and Recovery of GFP
After determining the conditions necessary for intein cleavage, ELP fusion proteins
were purified using ITC and subjected to the conditions described above (section 2.9.1) for
the respective intein. Following the overnight incubation period for intein cleavage, another
round of ITC was performed to separate the intein-ELP tag and recover the cleaved GFP.
Aggregation of the intein-ELP fragments were induced by the addition of (NH4)2SO4 to
1.0 M at room temperature for 30 min. The sample was centrifuged at 20,000 x g for 40 min
at room temperature to separate the intein-ELP pellet and aqueous GFP. Samples taken
pre- and post-ITC were analyzed using immunoblots.

31

CHAPTER 3: RESULTS

This study aimed to find an easier and more cost efficient way to purify a
recombinant protein of interest from crude plant extract. By utilizing fusion tags such as
ELPs and HFBI and replacing protease cleavage sites with an intein, transient expression
of the recombinant proteins was expected to result in increased accumulation levels as well
as simpler purification of the target protein.

3.1 Transient Expression of ELP Constructs
It was previously shown that short ELP tags of 40 repeats or less allow the
production of higher levels of recombinant protein, while larger ELP tags of 100 repeats
or more allow for more efficient purification of the fusion protein (Conley et al., 2009).
Therefore, constructs containing three different lengths of ELP fused to GFP and intein
(Fig. 5A, 5B) were designed and cloned into the pCaMterX vector. The resulting
expression vector was then transformed into electrocompetent EHA105 A. tumefaciens.
The constructs were infiltrated into N. benthamiana plants for transient expression
via agroinfiltration. Samples were collected four days post infiltration and extracted using
TEB supplemented with leupeptin and PMSF to prevent protein degradation. A construct
containing GFP with a KDEL ER retrieval motif (SPGK, Fig. 5F) was used as positive
control. Immunoblot analysis of tissue expressing the N-terminus-cleaving intein
constructs (N30, N60 and N90; Fig. 5A), revealed that only the N30 construct produced a
detectable protein band (Fig. 6A). The accumulation level of this fusion protein
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Figure 5. Constructs for transient expression of intein-GFP in N. benthamiana.
(A) and (B) represent the ELP constructs. (C) and (D) represent the HFBI constructs
NHFBI and CHFBI, respectively. (E) represents the HFBI-GFP construct, pJJJ161. (F)
represents the positive control SPGK. Common to all constructs are the tCUP translational
enhancer, the pr1b secretory signal peptide, the protein of interest (GFP), and a KDEL
motif for ER-retrieval. A StrepII tag is incorporated for alternative purification purposes.
The TEV in (E) represents the protease cleavage site. In (A) and (B), the “n” represents the
number of ELP pentapeptide repeats, and in this study, n = 30, 60 or 90 (shown above is
n = 30). The linkers used in (C) and (D) are L1, a flexible linker (GGGS)3 and/or L2, an
A. niger glucoamylase G1 linker.
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(A)

(B)

Figure 6. Expression of ELP constructs in N. benthamiana. (A) Immunoblot with two
replicates confirming expression of the GFP-intein-ELP constructs with the N-terminuscleaving intein and the various sizes of ELP. (B) Immunoblot with two replicates showing
expression of the C-terminus-cleaving inteins fused to GFP and various sizes of ELP.
These were hybridized with an anti-GFP antibody. The expected sizes for ELP30, ELP60
and ELP90 constructs are 90 kDa, 102 kDa, and 114 kDa, respectively. SPGK was used as
positive control; the expected size is 27 kDa.

34

was 0.40 ± 0.01% of TSP as determined by fluorometry against a concentration curve of
purified GFP. For the C-terminus-cleaving intein constructs (C30, C60 and C90), both C30
and C60 produced detectable protein bands by immunoblot analysis (Fig. 6B). The
accumulation levels for these two constructs were 0.44 ± 0.01% GFP/TSP and
0.19 ± 0.01% GFP/TSP, respectively. For the purpose of this study, only the higher
accumulating N30 and C30 were chosen for use in ITC optimization.

3.2. Design and Transient Expression of HFBI Constructs
The constructs used in this portion of the study were designed similarly to the ELP
constructs. The ELP tag was replaced with the HFBI tag and its corresponding linker(s).
The HFBI tag was flanked by one (for NHFBI) or two (for CHFBI) linkers to reduce
chances of improper folding by the intein and hydrophobin. The two linkers were (GGGS)3
linker (Fig. 5; L1) and the A. niger glucoamylase G1 linker (Fig. 5; L2). Joensuu et al.
(2010) had shown these two linkers to aid in the proper folding of HFBI. Because these
constructs were synthesized commercially, it was desirable to reduce the number of
restriction digest sites to allow for correct orientation in one step. For this reason, only the
EcoRI and the BamHI sites were incorporated into the gene (Fig. 5C and D) and were used
for directional cloning into the binary vector pCaMterX.
The HFBI constructs were transiently expressed in N. benthamiana plants using
agroinfiltration. Samples (leaf disks or whole leaf tissue) were collected four dpi and
extracted using PEB supplemented with protease inhibitors leupeptin and PMSF.
Accumulation levels were found to be 0.27 ± 0.02% GFP/TSP for NHFBI and
0.12 ± 0.01% GFP/TSP for CHFBI (Fig. 7) through fluorometry.
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Figure 7. Transient expression of HFBI constructs in N. benthamiana. Samples were
collected four days post infiltration and analyzed through immunoblotting. The blots were
hybridized with an anti-GFP primary antibody. The expected sizes for NHFBI and CHFBI
are 86 kDa and 88 kDa, respectively. The size of spliced GFP is 27 kDa. The number
corresponds to the volume of extract (µl) loaded in each lane.
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3.3. Aqueous Two-Phase System with HFBI Constructs
To study the purification of the HFBI constructs using ATPS, plant tissue samples
were collected four dpi and proteins were extracted with PEB* (PEB minus leupeptin and
PMSF). The crude extract was then subjected to ATPS purification with the surfactant
Triton X-114 as described in section 2.8.1. To determine the success of the purification,
samples were collected throughout the process (refer to Fig. 2A): the crude extract (E); the
aqueous layer (A) after the addition of surfactant; and the purified product in the second
aqueous phase after the removal of surfactant by the addition of isobutanol (P). These
samples were analyzed by immunoblotting. The results showed the hydrophobin fusions
(NHFBI and CHFBI) were not detected in the aqueous phase nor in the purified product
(Fig. 8A). To determine if this result was due to a technical error or to the inability of this
protein to purify using ATPS, a GFP-HFBI construct called pJJJ161 was used as a positive
control. This was previously shown to accumulate at very high levels and to purify very
well by ATPS (Joensuu et al., 2010). Aqueous two-phase system carried out with GFPHFBI showed that most of the protein was recovered in the purified fraction (data not
shown). Purification using another surfactant, Agrimul NRE 1205, did not lead to a
separation in phases following a two hour incubation period (data not shown).
It was possible that the GFP-intein-HFBI proteins were not purified by ATPS since
the accumulation levels were 100 times lower than GFP-HFBI, which is shown to
accumulate at 20-40% TSP (Joensuu et al., 2010; Saberianfar et al., 2015). To examine if
a higher concentration of HFBI could help pull the HFBI fusions into the surfactant
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(A)

(B)

Figure 8. Aqueous two-phase system for HFBI constructs and pJJJ161. Immunoblots
detected with anti-GFP antibody were used to determine the phases in which GFP and GFP
fusions resided during ATPS with Triton X-114. (A) ATPS with NHFBI and CHFBI alone.
(B) ATPS under spiked conditions: WT (wild type), NHFBI and CHFBI extracts were
mixed with equal volumes of pJJJ161 extract, labeled 161, N161 and C161, respectively.
The expected size of pJJJ161 is 35 kDa (arrowhead). The expected sizes of NHFBI and
CHFBI are 86 kDa and 88 kDa (arrow). E = crude extract; A = aqueous (non-surfactant)
phase; P = second aqueous phase (purified product).
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phase, extracts of tissue infiltrated with the HFBI fusion constructs were spiked with equal
volumes of extracts of tissue infiltrated with GFP-HFBI (pJJJ161) and the effectiveness of
spiking was compared among the different fusion proteins. The wild type (WT) extract
spiked with an equal volume of GFP-HFBI was used as a control. Results showed that
pJJJ161 was successfully recovered in the purified fraction by ATPS (Fig. 8B), although it
was not 100% efficient as some of the protein was still detected in the aqueous phase.
However, when the HFBI constructs were spiked with GFP-HFBI, although the aqueous
phase showed similar results to WT extract spiked with GFP-HFBI, the purified fractions
did not detect any of the intein-HFBI fusion constructs. All three samples (Fig. 8B) showed
a band at 60-75 kDa, possibly a dimer or trimer formed from either the GFP or GFP-HFBI.
Thus, the addition of more HFBI did not help increase the odds of successful purification
of HFBI constructs NHFBI and CHFBI.
In an attempt to track where the HFBI fusions were located throughout the steps of
ATPS, photos were taken under UV light during the purification process. The visual
difference in fluorescence intensity between WT and pJJJ161 under UV light can be seen
in Figures 9A (right) and 9B (right), respectively. With the addition of surfactant, it became
difficult to track GFP-HFBI because chlorophyll was also pulled into the surfactant phase
(Fig. 9C). However, the addition of isobutanol successfully separated GFP-HFBI from
chlorophyll and other proteins (Fig. 9D). While the mixed samples (N161 and C161) also
showed fluorescence in the purified phase, the results from the immunoblot (Fig. 8B)
showed that this fluorescence was from GFP-HFBI as opposed to the intein-HFBI fusions.
In conclusion, the NHFBI and CHFBI fusion proteins were unable to be purified via ATPS.
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(A)

(B)

(C)

(D)

Figure 9. Aqueous two-phase system under visible and UV light. Images were taken
under visible (left) and UV light (right). (A) Wild type extract before addition of surfactant.
(B) Crude extract of equal volumes of pJJJ161 and WT. (C) Phase separation after the
addition of Triton X-114 to pJJJ161/WT. Upper layer is the non-surfactant layer. (D)
Lower phase of (C) was removed and isobutanol was added. Phase separation shows
GFP-HFBI fusions in the lower phase and other plant proteins in the upper phase.
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3.4 Optimal Conditions for Inverse Transition Cycling
To isolate the ELP fusions from the crude extract, ITC was used to salt out the ELP
aggregates prior to resolubilization of the fusion proteins. Using 0.4 M (NH4)2SO4 at 37°C
as a starting point, which are the conditions set out by Duvenage et al. (2013), this study
was aimed to optimize both the temperature and salt concentration needed to obtain the
highest recovery of the ELP fusion protein, as well as the purified GFP after intein
cleavage. The process of ITC was carried out in the following steps: the crude extract (E)
was subjected to a salt and heat treatment and was centrifuged; the supernatant (S1) was
then removed – S1 should be void of any fusion protein; the pellet was resuspended in a
cold buffer to resolubilize the fusion protein; after it was centrifuged again, the supernatant
containing the solubilized fusion protein (S2) was recovered and the remaining pellet was
resuspended (P) for analysis. The starting conditions of 0.4 M (NH4)2SO4 at 37°C outlined
by Duvenage et al. (2013) resulted in the loss of the fusion protein into the pellet
(Fig. 10A), which could indicate that the salt concentration was too high, and possibly
denatured the fusion protein in the extract. Therefore, the salt concentration was decreased
to 0.2 M. I found that most of the fusion protein was still in the pellet fraction under reduced
salt concentration, although a small amount of protein was now present in S2. This result
suggests that lowering the salt concentration itself was not enough to improve
resolubilization of this particular ELP fusion at 37°C. To examine if the temperature at
37°C may have caused irreversible precipitation, the same salt conditions (0.2 M and 0.4 M
ammonium sulfate) were tested at 30°C (Fig. 10B) and 23°C (Fig. 10D). As the
temperature

was

reduced

to

30°C,
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then

to

23°C,

the

amount

of

(A)

(B)

(C)

(D)

(E)

Figure 10. Testing of ITC conditions for the purification of C30 using (NH4)2SO4.
Immunoblots of (A) ITC performed at 37°C, (B) and (C) ITC performed at 30°C, and (D)
and (E) ITC performed at 23°C. Blots were hybridized with an anti-GFP antibody. All
lanes were loaded with the equal volumes of sample. E = crude extract; S1 = supernatant
after hot spin; S2 = supernatant after cold spin; P = resolubilized pellet after completion of
ITC.
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unaggregated protein remaining in S1 increased and the band in S2 was fainter than in S1
at 0.2 M salt, and fainter than in the pellet at 0.4 M salt. These results meant the conditions
were not enough to induce full aggregation of the fusion proteins. With the focus of
industrial purposes in mind, treatments with increased concentrations of salt were
performed only at 30°C and 23°C to decrease the amount of heat that would be required.
Similar results were noted when performing ITC at the three temperatures with the various
salt concentrations with N30 (data not shown).
At increased salt concentrations of 0.8 M and 1.0 M, complete aggregation of the
ELP fusion protein was seen, as noted in the absence of a band in the S1 phases (Fig. 10C
and E). At 23°C, the purification efficiency showed that ~50% of the ELP fusion protein
was recovered in the S2 fraction and the other half remained insoluble in the pellet. For
industrial purposes, purification at room temperature is more desirable and energy efficient
than at higher temperatures. Thus, the conditions at room temperature and with 1 M
(NH4)2SO4 were used in the next study: purification through membrane ITC.

3.5. Purification of ELP Fusions Using Membrane ITC
Membrane ITC (Fig. 1B) is a modified version of the regular centrifugation ITC
(Fig. 1A). It also uses salt and heat to precipitate the fusion proteins. However, instead of
centrifuging the aggregates, the sample is passed through a membrane to catch the
aggregates while allowing other proteins to pass through. Using the conditions set out in
section 3.4, aggregation of the ELP fusions for the pre-filtered crude extract was induced
at room temperature with 1.0 M (NH4)2SO4. The initial filtering of the extract showed no
loss in the protein of interest (data not shown). Filtration of the aggregated ELP fusions
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showed complete aggregation (Fig. 11). The wash through showed none of the fusion
protein, as expected. Elution by gravity of the purified fraction was carried out overnight
at 4°C in 50 mM Tri-HCl with 0.1% v/v Triton X-100. A very minimal amount of the
purified and resolubilized ELP fusion was observed in the P1 fraction. Much of the fusion
protein was found in the P2 fraction for C30, unable to pass through the membrane. This
fraction was recovered by taking a small volume of elution buffer and washing the
membrane with it. Although it seems only a small amount of unsolubilized protein was
retained in the P2 fraction of N30, the amount of protein detected in P1 and P2 does not
sum up to the initial amount found in the extract. This indicates that the fusion proteins
were possibly trapped in the pores of the membrane, thus not making mITC a feasible
choice for these particular proteins.

3.6 Intein Cleavage in Crude Extract
Although purification with mITC and ATPS both proved unsuccessful, intein
cleavage could still be induced in crude leaf extracts of N30 and C30 for ITC purposes.
The N30 cleaves at the N-terminus and this splicing is mediated by the addition of DTT to
50 mM and/or 4-HT. A pH change to 5.5 and/or the addition of 4-HT induces cleavage at
the C-terminus of the C30 construct. The efficiency of intein splicing was determined by
the amount of cleaved GFP detected after the 18-24 hour incubation period. Intein cleavage
of N30 with 50 mM DTT was detected by shown to be very inefficient. Cleavage with
4-HT and DTT/4-HT was not detected (Fig. 12). The effect of the pH change, without the
addition of 4-HT, in C30 samples was sufficient for inducing cleavage of
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Figure 11. Membrane ITC with N30 and C30 at room temperature with 1.0 M
(NH4)2SO4. Immunoblot of mITC were hybridized with anti-GFP antibody. After inducing
aggregation of the ELPs, the suspension was passed through a 0.22 µm PVDF membrane
to capture all the aggregates while allowing background plant proteins to pass through.
Cold 50 mM Tris-HCl with 0.1% v/v Triton X-100 was used for resolubilization of ELP
fusions. The expected sizes of N30 and C30 are 90 kDa with purified product in P1. Equal
volumes of sample were loaded into each lane. E = crude extract; F = filtrate after
incubation in (NH4)2SO4; W = wash with 1.0 M (NH4)2SO4; P1 = purified product left
overnight to elute; P2 = product left on top of membrane.
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Figure 12. Intein cleavage treatments for crude extracts of N30 and C30. An
immunoblot detected with anti-GFP antibody was used to determine efficiency of intein
cleavage. Samples were incubated for 24 hours in a water bath at room temperature. The
conditions set for N30 were 50 mM DTT alone (D), 10 µM 4-HT (HT) alone and a
combination of both. For C30, the cleavage conditions included a change in pH to 5.5,
addition of 10 µM 4-HT and a combination of the two. Control treatments = hyphen. Equal
volumes of crude extract (E) and samples of different treatments were loaded into each
well.
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GFP from the intein-ELP fusion tag. The treatment with 4-HT alone could not induce as
much splicing as with a pH change. Thus, only a pH change is required for the cleavage of
GFP from the C30 fusion protein. Crude extract with no treatments for the same incubation
period showed no detectable cleavage.

3.7 Recovery of GFP from Cleaved Intein-ELP Fusions
The final step was to string together every successful method to create a complete
purification process. I first used centrifugation-based ITC to purify N30 and C30 extracts.
Then, based on the results from intein cleavage in crude extract, cleavage was induced by
adding DTT to 50 mM for the purified N30 fraction, while cleavage for the C30 was
induced by changing the pH to 5.5. After the overnight incubation period, a second round
of ITC was performed at room temperature by adding (NH4)2SO4 to a concentration of
1.0 M. From the immunoblots, spliced GFP was not detected in the expected aqueous phase
(Fig. 13; lane “S3”). This showed that the intein cleavage step was not efficient enough to
cleave the GFP from the intein-ELP tag (Fig. 13; lane “pH” or “D”). Therefore, the second
round of ITC was only able to purify the fusion protein in the resulting pellet (Fig. 13; lane
“P2”).
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(A)

(B)

Figure 13. Recovery of cleaved GFP through ITC, post intein cleavage. Immunoblots
of A) N30 and B) C30 through ITC, 24 hour intein cleavage with the respective cleaving
reagents and recovery of spliced GFP via another round of ITC, using anti-GFP antibody.
The expected sizes of N30, C30 and spliced GFP were 86 kDa, 88 kDa and 27 kDa,
respectively. Equal volumes of sample were loaded into each lane. E = crude extract; S1 =
supernatant after hot spin; S2 = supernatant after cold spin; P1 = resuspended pellet after
cold spin; D/pH = DTT or pH treatment for intein cleavage; S3 = recovered cleaved GFP
after second hot spin; P2 = resuspended pellet after hot spin.
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CHAPTER 4: DISCUSSION

4.1 Transient Expression of ELP and HFBI Fusions in N. benthamiana
This study aimed to purify recombinant proteins fused to intein-ELP and
intein-HFBI fusion tags produced through transient expression using agroinfiltration in
N. benthamiana. Following the successful purification of the recombinant proteins, the
fusion tag was cleaved with the help of inteins. This provides a method that is more cost
effective than traditional purification strategies such as chromatography, and also reduces
the need for expensive proteases required for the cleavage of the tag at a protease site.
Green fluorescent protein is often used as a biological marker due to its stability and its
ability to be fused to another protein without alteration of function (Zimmer, 2002). The
plants were able to produce both ELP- and HFBI-GFP fusions though the accumulation
levels varied between the different constructs. Consistent with the work of Conley et al.
(2009), it was found that the fusion proteins containing fewer repeats of ELP (i.e. 30
repeats) resulted in higher accumulation levels than those with 60 or 90 ELP repeats, which
accumulated at much lower levels or not at all (Fig. 6). The HFBI constructs containing
the intein accumulated at much lower levels than if only GFP or GFP-HFBI was expressed.
Accumulation levels for these are reported to be 18% and 38% GFP/TSP, respectively
(Joensuu et al., 2010).
As stated by Gräslund et al. (2008), in a study performed with E. coli, the
expression levels of larger proteins versus smaller ones in a soluble form was greatly
reduced. This could explain the lack of the larger fusion proteins, which range from 90 kDa
to 114 kDa, during detection through immunoblotting – the proteins either accumulated at
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very low levels or they were lost in the insoluble fraction of the crude extract. However,
for this particular study, the focus is on the purification of these fusion proteins and not the
accumulation levels of these proteins. Therefore, as N30 and C30 both accumulated to
typical levels (Hood et al., 2002) of 0.4-0.5% GFP/TSP, these two constructs were chosen
for ITC purification.

4.2 Purification of ELP-intein- and HFBI-intein-GFP Fusion Proteins
In this study, GFP was fused to intein-ELP or intein-HFBI, allowing the fusion to
take on the unique property of each tag. Fusion to the ELP tag passed on the ability to
perform a reversible aggregation/solubilization as required in the ITC purification process.
Traditional ITC calls for the use of NaCl. However, Duvenage et al. (2013) found that they
could precipitate their protein of interest at 37°C with 0.4 M (NH4)2SO4. This agrees with
the results of Fong et al. (2009) who improved their previous methods (which used NaCl)
by testing various combinations of the Hofmeister salts and their efficiency in the
precipitation of their ELP-tagged proteins. They found that they could achieve the same
result with a lower Tt and a lower molarity of (NH4)2SO4 versus using a higher molarity of
NaCl at a higher temperature. Thus, the starting condition used for ITC was 37°C with
0.4 M (NH4)2SO4. The temperatures and salt concentrations were experimented with until
a feasible combination was determined. It was found that ITC could be performed using
1.0 M (NH4)2SO4 at room temperature (23ºC; Fig. 10E). This yielded both complete
aggregation of the fusion protein as well as ~50% recovery of the resolubilized protein.
Fong et al. (2009) also reported recovery of approximately 50% for their ELP-fused GFP.
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This improvement is useful for industrial purposes as high concentrations of
sodium chloride can corrode stainless steel and other equipment used in manufacturing. As
well, because ammonium sulfate-based precipitation systems are common practice,
integrating this method is not farfetched. In addition, because this method works at room
temperature, it reduces the amount of energy required to make this purification process
work, thus reducing the overall cost.
Although Phan and Conrad (2011) reported promising findings for the use of the
purification method of membrane ITC, this method does not appear to be appropriate for
every protein. They were able to recover the majority of their protein of interest. However,
following their methods, I was unable to obtain the same results. During the overnight
elution, very little of the ELP fusions were resolubilized. Washing the membrane did not
reveal the missing unsolubilized proteins. This could be due to the proteins being caught
in the membrane pores, unable to pass through or to be released. The difference between
Phan and Conrad’s (2011) proteins and the ELP fusions I studied is the presence of the
intein. This leads me to believe that the intein, whether it be shape, size, or another
characteristic, could be the reason why the ELP fusion proteins could not pass through the
membrane.
Aqueous two-phase system is a purification system that allows separation of
proteins into different phases. Because of the amphipathic nature of hydrophobins and their
capability for transferring this property to their fusion partner, the whole fusion protein is
able to undergo the process of ATPS upon the addition of a surfactant. Hydrophobins
assemble into micelles, pulling the fused protein along with them into the surfactant phase,
while most other proteins remain in the aqueous phase. Keeping this in mind, the improper
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folding of the four disulfide bridges can disrupt the stability of the molecule (Hakanpaa et
al., 2004) and result in the hydrophobins not forming proper micelles that can be pulled
into the surfactant phase. In this study, the designing of the constructs took this into
consideration with the addition of linkers between the intein and HFBI tag to allow for
proper folding of HFBI. However, my results showed that the fusion proteins are not pulled
into the surfactant phase after the addition of Triton X-114 (Fig. 8A). This could be the
result of the very large intein (~50 kDa) interfering with the folding process, suggesting
that the linker(s) may not have been long enough to give the HFBI adequate space to fold
properly.
Another possibility is that a minimum accumulation level of HFBI may be needed
to induce micelle formation. Protein bodies are one of several specialized protein storage
organelles that are commonly found in seeds (Khan et al., 2012). Formation of protein
bodies is thought to help increase accumulation levels by storing large amounts of
recombinant proteins in a stable and safe environment (Conley et al., 2011). Gutiérrez et
al. (2013) found that protein bodies only form when the accumulation levels of
recombinant protein are over the threshold of 0.2% per TSP. The accumulation level of the
positive control GFP-HFBI is much higher than those of the HFBI constructs (NHFBI and
CHFBI) used in this study, which were 0.27% and 0.12% GFP/TSP, respectively.
Therefore, like the formation of protein bodies, there is the possibility that there must be
enough HFBI proteins, in other words, high enough accumulation level, so that the proteins
can interact with each other to form micelles, and the levels achieved by the constructs in
question were too low for this to happen. To test if this theory was true, the HFBI constructs
were spiked with pJJJ161 (GFP-HFBI) to see if the increased concentration of HFBI aids
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in micelle formation. The results from this experiment showed that only the GFP-HFBI
was recovered in the purified fraction and the CHFBI and NHFBI are not be detected
beyond the crude extract (Fig. 8B).
Although the above reasons are all plausible, there is also the possibility that HFBI
is simply not compatible with these particular protein fusions. The accumulation levels and
purification processes of ELP and HFBI were compared in a recent study of ELP and HFBI
by Phan et al. (2014). Because of their known association with enhancing the accumulation
levels of recombinant proteins and their ease during purification (Conley et al., 2009;
Joensuu et al., 2010), the fusion tags were added to a sequence coding for hemagglutinin
subtype 5 (H5). The results from Phan et al. (2014) showed that while the ELP fusions
showed a significant increase in expression levels compared to H5 alone, the addition of
HFBI did not affect the expression level at all. Because these levels were very low (less
than 0.05% per TSP), purification by ATPS was not attempted. This further supports the
idea that a certain accumulation level of HFBI fusion proteins is needed to induce the
formation of micelles.

4.3 Controlled Intein Cleavage in N30 and C30
The controlled induction of splicing of a protein of interest and its fusion tag
mediated by an intein can be a more cost effective method since this separation can be
catalyzed by common reagents rather than expensive proteases. When undergoing the
process of intein splicing, the reducing agent DTT attacks the thioester bond at the
N-terminus, thus inducing cleavage (Chong et al., 1997). C-terminal cleavage is
determined by the penultimate His residue which acts as a proton donor in the presence of
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an acidic pH change. This exchange of protons induces cyclization of asparagine, forming
succinimide as the intermediate (Wood et al., 1999). Therefore, as predicted, addition of
DTT and a pH change were enough to induce cleavage in the crude extracts of N30 and
C30, respectively (Fig. 12). However, cleavage at the N-terminus was not as efficient as
the pH change and was barely detected. Similar results were noted by Hendy (2009) where
only cleavage at the C-terminus by pH change was detected when he performed a similar
experiment using extracts from BY-2 cells. This being said, when working with ITCpurified N30 and C30, the efficiency of either intein cleavage was not high enough and
after the second ITC, only the intact fusion protein was detected.
This particular intein was modified to cleave only in the presence of 4-HT, but was
discovered to only reduce the amount of in vivo splicing (Buskirk et al., 2004). My results
also indicate, similar to those of Hendy (2009), that the addition of this synthetic estrogenlike molecule did not enhance cleavage at either terminus (Fig. 12). This could be due to
the intein not being dependent on the 4-HT to cleave since one terminal residue in each
intein was altered. This waives the requirement of 4-HT for the proper conformational
change in the intein, thus rendering it ineffective.

4.4 Summary and Future Work
Plants can be used as an alternative platform for the production of recombinant
proteins. They are cheaper to maintain because they do not require the same amount of care
and nutrients as mammalian cultures, but at the same time, they can perform complex posttranslational modifications required for many of these eukaryotic proteins. Nevertheless,
there are drawbacks to plants. They have low accumulation levels for many proteins as
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well as low recovery during purification. Fusion tags such as ELP and HFBI can counter
the low accumulation levels often found in plants, as well as aid in simpler forms of
purification of the recombinant proteins. In this study, GFP fused to intein-ELP and inteinHFBI were transiently expressed in N. benthamiana and accumulated at levels of 0.2% to
0.5% GFP/TSP. The tags must then be cleaved to yield a purified product. An
M. tuberculosis RecA intein was modified to cleave only in the presence of the small
molecule 4-HT (Buskirk et al., 2004) and then further modified to cleave only at one
terminus (Hendy, 2009). This intein’s role in purification is to reduce the need for a
protease cleavage site, which would otherwise result in very high costs. Contrary to my
hypothesis, mITC and ATPS did not seem to work with the specific proteins designed for
this study, but ITC showed promising results. About 50% of the fusion protein was
recovered in a soluble form at room temperature with a lower concentration of ammonium
sulfate than would be required with the more commonly used sodium chloride. As well,
inducing intein splicing with simple reagents such as DTT and HCl resulted in the cleavage
of GFP from the fusion tag and intein. These low cost reagents can be an advantage in an
industrial setting. Confirming my hypothesis, the pH cleavage of C30 resulted in more
efficient cleavage than N30 with DTT. However, the efficiency of intein cleavage was not
enough to induce complete removal of the intein-ELP tag and therefore, during the second
round of ITC, cleaved GFP was not detected. Thus, between decreased accumulation levels
and poor cleavage results to obtain the purified protein, modifications would have to be
made to allow this intein to be biotechnologically effective.
From this study, it appears that the added estrogen receptor site is not necessary for
the cleavage of a protein of interest at either end of the intein. As stated by Buskirk et al.
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(2004), it was found that the receptor site only decreased the splicing frequency but did not
moderate the splicing of the intein. Because the termini of this intein were altered so that
it would only cleave on one end, as well as the fact that 4-HT does not play a role in
splicing, removing the estrogen receptor can be tested to see if a smaller intein with these
modified termini results in higher accumulation levels. This would result in a mini intein
gene about 600 bp in length versus the one used, which was over 1.2 kb. In turn, this could
possibly increase the accumulation levels of the intein fusions and result in more efficient
splicing.
In regard to hydrophobins and ATPS, it appears that HFBI is not folding properly,
so modifications would have to be made to the construct itself. For instance, if the intein’s
folding is affecting HFBI’s folding, then a longer linker, or more repeats of the GGGS
linker, can be added to ensure more space between the two to increase chances of proper
folding. This could also increase the success of ATPS downstream as proper micelles
would form. As well, HFBI can be replaced with another hydrophobin to determine if it
was specifically this hydrophobin’s folding that is incompatible with the intein’s.
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